IMV Stock Falls After Interim Data From Lead Candidate In Blood Cancer Subtype
February 13, 2023 at 10:29 AM EST
IMV Inc(NASDAQ: IMV)announced preliminary datafrom the VITALIZE Phase 2B trial evaluating its lead DPX product, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.